Date: 2015-05-18
Type of information: Company acquisition
Acquired company: Biostatem (France)
Acquiring company: Axonal (France)
Amount: undisclosed
Terms: * On May 18, 2015, Axonal and Biostatem announced the merge of their business and operations to form a leading CRO in Europe on Post-Marketing activities (\" Real World Studies \").
Details: The new entity, \" Axonal -Biostatem \" with its strong experience entrenched for 25 years, will include 50 employees and will operate on the European market, but also Asian and American through strong targeted partnerships. The group will be focused on projects with high added value of expertise in the fields of pharmaco-epidemiology, medico-economy, clinical trials and biometry. The group has strong growth ambitions over the next 5 years, \"With this merge we are doubling our capacity in data management and statistics and optimizing the location of our CRAs on two sites. The international development and reconciliation with synergistic players are the two essential levers to our growth, this first operation is a key passage to our long- term goals which are to reach 100 employees and € 10 Million by 2020 \" , says Denis Comet, president of Axonal.
Axonal is a European CRO, providing solutions and expertise in clinical trials and post-marketing studies for 25 years, with registered office at Nanterre, near Paris (France), with a presence in London (UK), Modena (IT), Prague (CZ) and Warsaw (PL). The company, which employs 40 people and has a turnover of € 4 Million, accounts for a very wide panel of customers from the pharmaceutical industry and academia, as well as medical devices, cosmetics and food manufacturers. It is recognized for its expertise in post-marketing evaluation studies that require high expertise in the fields of pharmaco-epidemiology and medico-economy. Biostatem is a French CRO based in Montpellier and acting in the market of clinical trials and post-marketing studies for 14 years. The company, which employs eight people and has a turnover of 700 K € has developed highly specialized expertise in the analysis of study data it manages for numerous pharmaceutical, medical device and academic customers. The company provides full monitoring of all phases of studies and bases its work on the practice of true interactivity with customers.
Related: CRO
